News

Prior to joining the company, Mr Patel has worked as a general manager, Olefins and NGLs for Chevron Phillips Chemical Company where he was responsible for all aspects

The collaboration utilises Theraclone’s I-Star technology to discover protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza. Sofar, Theraclone has received over $9m in

Prisym Medica is designed for life science companies that need to design, validate and approve labelling on a variety of products, from medical devices to pharmaceuticals and into

The collaboration calls for Cornerstone to apply its Emulsiphan cancer selective delivery nanotechnology platform to a class of agents developed at the NCI’s Center for Cancer Research Nanobiology

The patent covers vacuum microwave dehydration of a wide range of materials in either solid, liquid or frozen state including enzymes, drugs, vitamins, antimicrobial agents and preservatives and

Rogers said that the total purchase price for the intellectual property, technology assets and stock of SK Utis is $29.1m. The agreement calls for Rogers to acquire a

Indomethacin is therapeutically equivalent to the reference-listed drug Indocin IV, by Lundbeck. The company is planning to launch Indomethacin for injection in the second quarter of 2010. APP

Boehringer said that the study findings have demonstrated that the patients with advanced PD who were treated with Mirapex ER experienced superior symptom relief versus placebo. In addition,

The Germany-based pharma company said that the decision was taken in alignment with the FDA’s clinical hold placed on the investigational new drug (IND) application for Stimuvax. In